Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma (Q57599632)
article
Language:
Current Data About Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma
(P31) (Q13442814)
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P50) (Q152760)
(P1545) 9
(P1932) J Dausset
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(Q117474702)
(P1545) 4
(P1932) LM Nadler
L M Nadler
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P304) 1105-10

1105-1110
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P407) (Q1860)

(P433) 6
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P478) 57
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P577) +1981-06-00T00:00:00Z

Monday, June 1, 1981
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P921) (Q79460)
(P887)

(Q29496)
(P887)

(Q18553852)
(P887)

(Q6708247)
(P887)

(Q422248)
(P887)

(P1433) (Q885070)
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P1476) "Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma" (language: en)
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P2093) A Bernard
(P1545) 1
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

L Boumsell
(P1545) 2
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

E L Reinherz
(P1545) 3
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

J Ritz
(P1545) 5
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

H Coppin
(P1545) 6
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

Y Richard
(P1545) 7
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

F Valensi
(P1545) 8
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

G Flandrin
(P1545) 10
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

J Lemerle
(P1545) 11
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

S F Schlossman
(P1545) 12
(P248)
(P356) 10.1182/blood.v57.6.1105.bloodjournal5761105
(P854) https://api.crossref.org/v1/works/https://doi.org/10.1182/blood.v57.6.1105.bloodjournal5761105
(P813) Tuesday, September 6, 2022

(P4510) (Q422248)
(P887)

other details